Histopathological and immunohistochemical characteristics of acquired cholesteatoma in children and adults

Egyptian Journal of Ear, Nose, Throat and Allied Sciences

Volumn 13, Issue 1, 2012, Pages 7-12

  Bassiouny, Mohammed ^a   Badour, Nahed ^a   Omran, Ahmed ^a   Osama, Hani ^a  

^a ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

Adult; Children; Cholesteatoma; Histopathology; PCNA

Indexed keywords

EID: 84871994811     PISSN: 20900740     EISSN: 20903405     Source Type: Journal    
DOI: 10.1016/j.ejenta.2012.02.007     Document Type: Article

References (24)

1. Telian S.A., Schmalbach C.E. Chronic otitis media. Ballenger's Otorhinolaryngology Head and Neck Surgery 2003, 261-293. BC Decker Inc, Hamilton, Ontario. 16 ed. J.B. Snow, J.J. Ballenger (Eds.).
2. Albino A.P., Kimmelman C.P., Parisier S.C. Cholesteatoma: a molecular and cellular puzzle. Am J Otol 1998, 19(1):7-19.
3. Aberg B., Westin T., Tjellstrom A., Edstrom S. Clinical characteristics of cholesteatoma. Am J Otolaryngol 1991, 12(5):254-258.
4. Ferlito A., Devaney K.O., Rinaldo A., et al. Clinicopathological consultation. Ear cholesteatoma versus cholesterol granuloma. Ann Otol Rhinol Laryngol 1997, 106(1):79-85.
5. Lim D.J., Saunders W.H. Acquired cholesteatoma: light and electron microscopic observations. Ann Otol Rhinol Laryngol 1972, 81(1):1-11.
6. Kurihara A., Toshima M., Yuasa R., Takasaka T. Bone destruction mechanisms in chronic otitis media with cholesteatoma: specific production by cholesteatoma tissue in culture of bone-resorbing activity attributable to interleukin-1 alpha. Ann Otol Rhinol Laryngol 1991, 100(12):989-998.
7. Wright C.G., Meyerhoff W.L. Pathology of otitis media. Ann Otol Rhinol Laryngol Suppl 1994, 163:24-26.
8. Kuczkowski J., Kobierska-Gulida G., Izycka-Swieszewska E., Potocka M., Mikaszewski B., Sierszen W. Molecular control of bone resorption in chronic otitis media with cholesteatoma. Otolaryngol Pol 2010, 64(4):219-224.
9. Orisek B.S., Chole R.A. Pressures exerted by experimental cholesteatomas. Arch Otolaryngol Head Neck Surg 1987, 113(4):386-391.
10. Shohet J.A., de Jong A.L. The management of pediatric cholesteatoma. Otolaryngol Clin North Am 2002, 35(4):841-851.
11. Sudhoff H., Bujia J., Borkowshi G., et al. Basement membrane in middle ear cholesteatoma. Immunohistochemical and ultrastructural observations. Ann Otol Rhinol Laryngol 1996, 105(10):804-810.
12. Welkoborsky H.J., Jacob R.S., Hinni M.L. Comparative analysis of the epithelium stroma interaction of acquired middle ear cholesteatoma in children and adults. Eur Arch Otorhinolaryngol 2007, 264(8):841-848.
13. Mallet Y., Nouwen J., Lecomte-Houcke M., Desaulty A. Aggressiveness and quantification of epithelial proliferation of middle ear cholesteatoma by MIB1. Laryngoscope 2003, 113(2):328-331.
14. Dornelles C., da Costa S.S., Meurer L., Schweiger C. Correlation of cholesteatomas perimatrix thickness with patient's age. Braz J Otorhinolaryngol 2005, 71(6):792-797.
15. Dornelles C., Meurer L., Selaimen da Costa S., Schweiger C. Histologic description of acquired cholesteatomas: comparison between children and adults. Braz J Otorhinolaryngol 2006, 72(5):641-648.
16. de Dornelles C., da Costa S.S., Meurer L., Rosito L.P., Silva A.R., Alves S.L. Comparison of acquired cholesteatoma between pediatric and adult patients. Eur Arch Otorhinolaryngol 2009, 266(10):1553-1561.
17. Paunesku T., Mittal S., Protic M., et al. Proliferating cell nuclear antigen (PCNA): ringmaster of the genome. Int J Radiat Biol 2001, 77(10):1007-1021.
18. Garcia R.L., Coltrera M.D., Gown A.M. Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis. Am J Pathol 1989, 134(4):733-739.
19. Dietrich D.R. Toxicological and pathological applications of proliferating cell nuclear antigen (PCNA), a novel endogenous marker for cell proliferation. Crit Rev Toxicol 1993, 23(1):77-109.
20. Olszewska E., Chodynicki S., Chyczewski L., Rogowski M. Some markers of proliferative activity in cholesteatoma epithelium in adults. Med Sci Monit 2006, 12(8):CR337-CR340.
21. Shieh T.J., Ho K.Y., Kuo W.R., Chai C.Y., Lin C.S., Juan K.H. Evaluation of proliferative activity in middle ear cholesteatoma using proliferating cell nuclear antigen. Kaohsiung J Med Sci 1999 Aug, 15(8):468-474.
22. Bujia J., Sudhoff H., Holly A., Hildmann H., Kastenbauer E. Immunohistochemical detection of proliferating cell nuclear antigen in middle ear cholesteatoma. Eur Arch Otorhinolaryngol 1996, 253(1-2):21-24.
23. Hassmann-Poznanska E., Skotnicka B., Dzieciol J. Markers of epidermal proliferation in middle ear cholesteatoma. Otolaryngol Pol 2003, 57(4):505-511.
24. Sade J., Fuchs C. A comparison of mastoid pneumatization in adults and children with cholesteatoma. Eur Arch Otorhinolaryngol 1994, 251(4):191-195.